Fig 2. Association between cervical cancer screening rate and cervical cancer burden (A) and recurrent or metastatic cervical cancer burden (B) at the ZIP-3 level for the period 2017–2022.

Cervical cancer burden was defined as the prevalent number of cervical cancer diagnoses per 100,000 eligible female enrollees. Recurrent or metastatic cervical cancer burden was defined as the proportion of patients with cervical cancer who initiated system therapy. CC: cervical cancer; r/mCC: recurrent or metastatic cervical cancer.